168 related articles for article (PubMed ID: 32417543)
1. Drug repurposing approach to target FtsZ cell division protein from Salmonella Typhi.
Naz F; Mashkoor M; Sharma P; Haque MA; Kapil A; Kumar M; Kaur P; Abdul Samath E
Int J Biol Macromol; 2020 Sep; 159():1073-1083. PubMed ID: 32417543
[TBL] [Abstract][Full Text] [Related]
2. Screening of plant-based natural compounds as an inhibitor of FtsZ from Salmonella Typhi using the computational, biochemical and in vitro cell-based studies.
Naz F; Kumar M; Koley T; Sharma P; Haque MA; Kapil A; Kumar M; Kaur P; Ethayathulla AS
Int J Biol Macromol; 2022 Oct; 219():428-437. PubMed ID: 35932806
[TBL] [Abstract][Full Text] [Related]
3. Plumbagin inhibits cytokinesis in Bacillus subtilis by inhibiting FtsZ assembly--a mechanistic study of its antibacterial activity.
Bhattacharya A; Jindal B; Singh P; Datta A; Panda D
FEBS J; 2013 Sep; 280(18):4585-99. PubMed ID: 23841620
[TBL] [Abstract][Full Text] [Related]
4. Target Based Virtual Screening of New Leads Inhibitor against Bacterial Cell Division Protein FtsZ for the Discovery of Antibacterial Agents.
Mishra RC; Kumari R; Yadav S; Yadav JP
Med Chem; 2020; 16(2):169-175. PubMed ID: 30727908
[TBL] [Abstract][Full Text] [Related]
5. BT-benzo-29 inhibits bacterial cell proliferation by perturbing FtsZ assembly.
Ray S; Jindal B; Kunal K; Surolia A; Panda D
FEBS J; 2015 Oct; 282(20):4015-33. PubMed ID: 26258635
[TBL] [Abstract][Full Text] [Related]
6. A rhodanine derivative CCR-11 inhibits bacterial proliferation by inhibiting the assembly and GTPase activity of FtsZ.
Singh P; Jindal B; Surolia A; Panda D
Biochemistry; 2012 Jul; 51(27):5434-42. PubMed ID: 22703373
[TBL] [Abstract][Full Text] [Related]
7. Nanoparticle Fullerene (C60) demonstrated stable binding with antibacterial potential towards probable targets of drug resistant Salmonella typhi - a computational perspective and in vitro investigation.
Skariyachan S; Parveen A; Garka S
J Biomol Struct Dyn; 2017 Dec; 35(16):3449-3468. PubMed ID: 27817242
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial peptide CRAMP (16-33) stalls bacterial cytokinesis by inhibiting FtsZ assembly.
Ray S; Dhaked HP; Panda D
Biochemistry; 2014 Oct; 53(41):6426-9. PubMed ID: 25294259
[TBL] [Abstract][Full Text] [Related]
9. FtsZ inhibitors as a new genera of antibacterial agents.
Tripathy S; Sahu SK
Bioorg Chem; 2019 Oct; 91():103169. PubMed ID: 31398602
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of action of the cell-division inhibitor PC190723: modulation of FtsZ assembly cooperativity.
Elsen NL; Lu J; Parthasarathy G; Reid JC; Sharma S; Soisson SM; Lumb KJ
J Am Chem Soc; 2012 Aug; 134(30):12342-5. PubMed ID: 22793495
[TBL] [Abstract][Full Text] [Related]
11. Identification of agents targeting FtsZ assembly.
Panda D; Bhattacharya D; Gao QH; Oza PM; Lin HY; Hawkins B; Hibbs DE; Groundwater PW
Future Med Chem; 2016 Jun; 8(10):1111-32. PubMed ID: 27284850
[TBL] [Abstract][Full Text] [Related]
12. Discovery of promising FtsZ inhibitors by E-pharmacophore, 3D-QSAR, molecular docking study, and molecular dynamics simulation.
Qiu Y; Zhou L; Hu Y; Bao Y
J Recept Signal Transduct Res; 2019 Apr; 39(2):154-166. PubMed ID: 31355691
[TBL] [Abstract][Full Text] [Related]
13. Pharmacophore generation, atom-based 3D-QSAR, molecular docking and molecular dynamics simulation studies on benzamide analogues as FtsZ inhibitors.
Tripathy S; Azam MA; Jupudi S; Sahu SK
J Biomol Struct Dyn; 2018 Sep; 36(12):3218-3230. PubMed ID: 28938860
[TBL] [Abstract][Full Text] [Related]
14. Doxorubicin inhibits E. coli division by interacting at a novel site in FtsZ.
Panda P; Taviti AC; Satpati S; Kar MM; Dixit A; Beuria TK
Biochem J; 2015 Nov; 471(3):335-46. PubMed ID: 26285656
[TBL] [Abstract][Full Text] [Related]
15. Molecular dynamics analysis of the effects of GTP, GDP and benzimidazole derivative on structural dynamics of a cell division protein FtsZ from
Hakeem S; Singh I; Sharma P; Uppal A; Khajuria Y; Verma V; Uversky VN; Chandra R
J Biomol Struct Dyn; 2019 Oct; 37(16):4361-4373. PubMed ID: 30466358
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and evaluation of novel 9-arylalkyl-10-methylacridinium derivatives as highly potent FtsZ-targeting antibacterial agents.
Song D; Zhang N; Zhang P; Zhang N; Chen W; Zhang L; Guo T; Gu X; Ma S
Eur J Med Chem; 2021 Oct; 221():113480. PubMed ID: 33964649
[TBL] [Abstract][Full Text] [Related]
17. Targeting cell division: small-molecule inhibitors of FtsZ GTPase perturb cytokinetic ring assembly and induce bacterial lethality.
Margalit DN; Romberg L; Mets RB; Hebert AM; Mitchison TJ; Kirschner MW; RayChaudhuri D
Proc Natl Acad Sci U S A; 2004 Aug; 101(32):11821-6. PubMed ID: 15289600
[TBL] [Abstract][Full Text] [Related]
18. Virtual screening of potential inhibitor against FtsZ protein from Staphylococcus aureus.
Vijayalakshmi P; Nisha J; Rajalakshmi M
Interdiscip Sci; 2014 Dec; 6(4):331-9. PubMed ID: 25519150
[TBL] [Abstract][Full Text] [Related]
19. Drug repurposing: Fusidic acid as a potential inhibitor of M. tuberculosis FtsZ polymerization - Insight from DFT calculations, molecular docking and molecular dynamics simulations.
Akinpelu OI; Lawal MM; Kumalo HM; Mhlongo NN
Tuberculosis (Edinb); 2020 Mar; 121():101920. PubMed ID: 32279872
[TBL] [Abstract][Full Text] [Related]
20. The development of FtsZ inhibitors as potential antibacterial agents.
Ma S; Ma S
ChemMedChem; 2012 Jul; 7(7):1161-72. PubMed ID: 22639193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
